spacer
home > ebr > current issue
PUBLICATIONS

European Biopharmaceutical Review

ebr
Summer 2019

   
Text
PDF
bullet
Genomics and DNA
Advancements in Genealogy

The DNA of a New Industry

Futura Genetics’ Efi Binder delves into the rapidly progressing field of genome sequencing, expanding on the decreasing costs that are associated with this type of testing.
 
view
download pdf
bullet
ADCs as Therapeutics
Leveraging Automated Discovery Platforms

Easy as ADC

Dr Xin Liu at Sphere Fluidics emphasises the efficacy and reduced toxicities of novel antibody-drug conjugates as a promising yet costly means to treating life-limiting diseases.
 
view
download pdf
Analytical Techniques in Therapeutics

ADC Characterisation

Christopher M Bianchetti PhD, Henry J Parker, Katherine C Hanson PhD, and Stephen Gacheru PhD at PPD Laboratories illustrate how monoclonal antibody-based therapeutics are advancing cancer treatment.
 
view
download pdf
Antibody-Drug Conjugates in Chemotherapy

The ADC Jigsaw

Antibody-drug conjugates are good contenders in the fight against cancer. Dr Jenny Thirlway at Iksuda outlines how this route of cancer treatment is more effective in eradicating cancer cells and reducing side effects.
 
view
download pdf
bullet
Features
Choosing the Right Biomaterial

A View from the Bench

Barbara Vanhoecke at Rousselot investigates the possibility of removing endotoxins that have proven to be a hindrance in instances where using gelatin would be preferable.
 
view
download pdf
The Cancer Problem

Closer to the Cure

Christian Rommel at Roche advises companies to refrain from treating every step forward in cancer research as a potential cure. Rather, scientists should accept that finding a cure will be a more difficult journey than anticipated.
 
view
download pdf
Immunoncology Drug Development

Do More With Less

Dr Katie Chapple at Sartorius Stedim Biotech and Andrea Gomez-Donart at IntelliCyt outline the current advances in immunoncology, looking specifically at drugs that harness the immune system.
 
view
download pdf
Antibiotic Resistance

Fighting the Global Threat

DAs antibiotic resistance continues to plague the healthcare industry, Adrian Fellows at AGA Nanotech urges companies to unite and educate
 
view
download pdf
Achieving the Full Potential of Immunoncology

Leveraging Novel Therapeutics and Diagnostic Assays

Marisa Pearce at Molecular MD, an ICON company, argues that, although immunotherapy is nothing new, it has much untapped potential yet to be explored.
 
view
download pdf
Translational Safety

The Next Frontier

InSphero’s Judi Wardwell, Dr Radina Kostadinova, and Professor Armin Wolf believe in vitro tissue models to be the way forward in reducing attrition rates of drug candidates, ultimately improving patient safety and return on investment.
 
view
download pdf
Fermenting Peptides and Proteins

The Renaissance of Microbial Fermentation

The advent of cell culture systems ultimately led to increased interest of microbial-produced biopharmaceuticals, as told by Dr Vladas Bumelis at Northway Biotechpharma.

 
view
download pdf
bullet
Analytical Methods
AI and Multifactorial Data Analytics

A New Lens

Analytical tools are necessary for understanding the architecture of multifactorial diseases. Steve Gardner at RowAnalytics introduces the new generation of artificial intelligence and data analytics that can aid in the untangling of disease risk.


 
view
download pdf
Examining Process Residuals

Mass Spectrometric Analysis of Process-Related Impurities

Dr Richard L Easton and Dr Andrew J Reason at BioPharmaSpec demonstrate why mass spectrometry is a highly versatile tool for residual detection, even in the most complex of mixtures.
 
view
download pdf
bullet
Neurodegenerative Diseases
Systems Medicine and Drug Repurposing

An Answerable Challenge

Neurodegeneration and neurological disorders as a whole could be considered as the main cause of disability-adjusted years. Dr Hermann Mucke at H.M. Pharma Consultancy encourages the exploration of new drug combinations to drive treatment of such diseases.
 
view
download pdf
Targeting Aβ Oligomers

The Future of R&D in Alzheimer’s Disease

Dr Neil Cashman and Dr James W Kupiec at ProMIS Neurosciences explain the ways in which new investigational drugs are transforming clinical trial design and the R&D landscape.
 
view
download pdf
bullet
Regulars
In Brief

Great Expectations

EBR’s Industry Advisor Emile Bellott reviews rare disease progress in the biopharmaceutical arena.

 
view
download pdf
Immunology

The Factory for Next- Generation Therapies

EBR’s Editor Dr Deborah O’Neil recounts the themes of the issue, warning of the dangers of antimicrobial resistance while celebrating advancements in personal genetic data.
 
view
download pdf
   
spacer
Edited by
Dr Deborah O'Neil,
Chief Executive and Scientific Officer,
NovaBiotics Ltd
Published quarterly in
January, April,
July, and October

News and Press Releases

PCI Pharma Services Announces Further Expansion in San Diego to Maintain Industry-Leading Quality, Service and Flexibility

Philadelphia, PA – June 4, 2019 PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has announced the growth of its West Coast Clinical operations with expansion into its third facility in San Diego.
More info >>

White Papers

Overcoming research challenges with Adaptive Trials

PCI Pharma Services

There has been cause for concern within the pharmaceutical industry over the last five years, regarding increasing research and development costs, combined with a fall in the number of new drugs brought to market. In an attempt to overcome this issue there has been a significant rise in the use of adaptive clinical trial designs, whilst saving time and money as well as facilitating more effective decision making. One of the biggest challenges that pharmaceutical companies have experienced has been delivering compliant clinical trials supplies across diverse patient populations in the relatively short timeframes that adaptive trial designs require, remaining focused on ensuring that patient compliance and product quality is in no way compromised. This demand has led to the launch of fast response services that support Research and Development in responding to changing dosing regimens mid-trial.
More info >>

Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement